Remepy Announces Collaboration with Merck KGaA, Darmstadt Germany to Advance Hybrid Drugs Across Therapeutic Areas

April 28, 2026

More like this

Remepy to Collaborate with Merck KGaA, Darmstadt Germany to Advance Hybrid Drugs Across Therapeutic Areas

American Pharmaceutical Review

Merck partners Remepy in PDURS-focused alliance

Pharmaphorum

Merck KGaA and Remepy join forces to develop combo drug-digital therapies

Pharmaceutical Technology